Status | Study |
Not yet recruiting |
Study Name: Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma Condition: Bile Duct Cancer Intrahepatic Cholangiocarcinoma Date: 2017-03-13 Interventions: Combination Product: Melphalan/HDS |
Not yet recruiting |
Study Name: Adjuvant Capecitabine vs Gemcitabine Plus Cisplatin in Resected Extrahepatic Cholangiocarcinoma Condition: Cholangiocarcinoma Biliary Tract Cancer Adjuvant Chemother Date: 2017-03-09 Interventions: Drug: Gemcitabine plus cisplatin |
Recruiting |
Study Name: EUS BD vs ERCP TP for Pancreatic Cancer Condition: Pancreatic Cancer Pancreatic Adenocarcinoma Date: 2017-02-16 Interventions: Procedure: Endoscopic Ultrasound Guided Biliary Drainage |
Recruiting |
Study Name: Durvalumab(MEDI4736)/Tremelimumab in Combination With Gemcitabine/Cisplatin in Chemotherapy-naïve Biliary Tract Cancer Condition: Biliary Tract Neoplasms Date: 2017-02-06 Interventions: Drug: Durvalumab Durvalumab 1. |
Recruiting |
Study Name: A Study of Varlitinib in Japanese Subjects With Advanced or Metastatic Solid Tumours Condition: Advanced or Metastatic Biliary Tract Cancer Advanced or Metastatic Solid Tumors Date: 2017-02-02 Interventions: Drug: varlitinib Other Name: A |
Not yet recruiting |
Study Name: Nal-IRI With 5-fluorouracil (5-FU) and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Biliary-tract Cancer Condition: Adenocarcinoma Metastatic Biliary Tract Cancer Adenocarcin Date: 2017-01-23 Interventions: Drug: Arm NaI-IRI + 5-FU + Leucovorin (Arm A) |
Recruiting |
Study Name: Varlitinib in Combination With Gemcitabine and Cisplatin for Treatment naïve Advanced or Metastatic BTC Condition: Biliary Tract Cancer Date: 2016-12-08 Interventions: Drug: Varlitinib Per oral (PO) |
Completed |
Study Name: Early Palliative Care on Quality of Life of Advanced Cancer Patients Condition: Non-small Cell Lung Cancer Gastric Cancer Pancreatic Cance Date: 2016-12-04 Interventions: Other: Early Palliative Care Subjects who are randomized to the Standard Oncology Care with Early Pallia |
Not yet recruiting |
Study Name: Biweekly SOLAR, as First-line C/T in Pts With Gastric, Pancreatic and Biliary Cancers Condition: Gastric Cancer in Situ Pancreatic Cancers Biliary Cancers Date: 2016-11-15 Interventions: Drug: Oxaliplatin Oxaliplatin |
Recruiting |
Study Name: Study of Sulfatinib as Second-line Treatment in Patients With Biliary Tract Carcinoma Condition: Biliary Tract Cancer Date: 2016-11-11 Interventions: Drug: Sulfatinib Patients receive oral Sulfatinib at a dose of 300mg/d within 1 hour after breakfast (on |